Innoviz (INVZ) Stock Forecast, Price Target & Predictions
INVZ Stock Forecast
Innoviz stock forecast is as follows: an average price target of $5.67 (represents a 782.90% upside from INVZ’s last price of $0.64) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
INVZ Price Target
INVZ Analyst Ratings
Innoviz Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jul 10, 2024 | Mark Delaney | Goldman Sachs | $1.00 | $0.95 | 4.71% | 55.71% |
May 09, 2024 | Josh Cohen | Cantor Fitzgerald | $3.00 | $1.30 | 130.77% | 367.14% |
Dec 20, 2022 | - | J.P. Morgan | $13.00 | $3.94 | 229.95% | 1924.29% |
Aug 11, 2022 | - | Goldman Sachs | $8.00 | $6.05 | 32.23% | 1145.72% |
Innoviz Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 2 |
Avg Price Target | - | - | $2.00 |
Last Closing Price | $0.64 | $0.64 | $0.64 |
Upside/Downside | -100.00% | -100.00% | 211.43% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jul 11, 2024 | Wolfe Research | - | Peer Perform | Downgrade |
Jul 10, 2024 | Goldman Sachs | Buy | Neutral | Downgrade |
May 09, 2024 | Cantor Fitzgerald | Overweight | Overweight | Hold |
Nov 01, 2022 | WestPark Capital | - | Buy | Initialise |
Sep 20, 2022 | Prescience Point | - | Buy | Initialise |
Aug 11, 2022 | Goldman Sachs | Buy | Buy | Hold |
Nov 17, 2021 | Goldman Sachs | - | Buy | Upgrade |
Innoviz Financial Forecast
Innoviz Revenue Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | $1.01M | $1.58M | $878.00K | $1.80M | $1.77M | $1.66M | $2.08M | $1.01M |
Avg Forecast | $40.17M | $32.13M | $18.23M | $12.05M | $9.78M | $4.45M | $4.60M | $5.60M | $11.25M | $3.00M | $1.06M | $1.42M | $2.33M | $1.93M | $2.17M | $2.93M | $1.75M | $2.25M | $1.50M |
High Forecast | $40.17M | $32.13M | $18.23M | $12.05M | $9.78M | $4.45M | $4.60M | $5.60M | $11.25M | $3.00M | $1.06M | $1.42M | $2.33M | $1.93M | $2.17M | $2.93M | $1.75M | $2.25M | $1.50M |
Low Forecast | $40.17M | $32.13M | $18.23M | $12.05M | $9.78M | $4.45M | $4.60M | $5.60M | $11.25M | $3.00M | $1.06M | $1.42M | $2.33M | $1.93M | $2.17M | $2.93M | $1.75M | $2.25M | $1.50M |
# Analysts | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.71% | 0.68% | 0.45% | 0.83% | 0.60% | 0.95% | 0.92% | 0.67% |
Innoviz EBITDA Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | $-35.81M | $-34.50M | $-33.23M | $-28.58M | $-29.57M | $-30.28M | $-21.94M | $-72.54M |
Avg Forecast | $-24.10M | $-19.28M | $-10.94M | $-7.23M | $-5.87M | $-2.67M | $-2.76M | $-3.36M | $-6.75M | $-1.80M | $-636.00K | $-852.00K | $-1.40M | $-1.16M | $-1.30M | $-1.76M | $-1.05M | $-1.35M | $-900.00K |
High Forecast | $-24.10M | $-19.28M | $-10.94M | $-7.23M | $-5.87M | $-2.67M | $-2.76M | $-3.36M | $-6.75M | $-1.80M | $-636.00K | $-852.00K | $-1.40M | $-1.16M | $-1.30M | $-1.76M | $-1.05M | $-1.35M | $-900.00K |
Low Forecast | $-24.10M | $-19.28M | $-10.94M | $-7.23M | $-5.87M | $-2.67M | $-2.76M | $-3.36M | $-6.75M | $-1.80M | $-636.00K | $-852.00K | $-1.40M | $-1.16M | $-1.30M | $-1.76M | $-1.05M | $-1.35M | $-900.00K |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 42.03% | 24.68% | 28.65% | 21.98% | 16.80% | 28.84% | 16.25% | 80.60% |
Innoviz Net Income Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | $-34.80M | $-34.32M | $-34.20M | $-28.12M | $-30.23M | $-33.92M | $-26.43M | $-72.53M |
Avg Forecast | $-19.35M | $-20.20M | $-21.67M | $-21.67M | $-23.24M | $-22.04M | $-25.31M | $-24.17M | $-30.57M | $-35.97M | $-36.64M | $-36.64M | $-39.63M | $-39.41M | $-30.53M | $-29.98M | $-24.98M | $-26.64M | $168.40M |
High Forecast | $-19.35M | $-20.20M | $-21.67M | $-21.67M | $-23.24M | $-22.04M | $-25.31M | $-24.17M | $-30.57M | $-35.97M | $-36.64M | $-36.64M | $-39.63M | $-39.41M | $-30.53M | $-29.98M | $-24.98M | $-26.64M | $168.40M |
Low Forecast | $-19.35M | $-20.20M | $-21.67M | $-21.67M | $-23.24M | $-22.04M | $-25.31M | $-24.17M | $-30.57M | $-35.97M | $-36.64M | $-36.64M | $-39.63M | $-39.41M | $-30.53M | $-29.98M | $-24.98M | $-26.64M | $168.40M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 0.95% | 0.87% | 0.87% | 0.92% | 1.01% | 1.36% | 0.99% | -0.43% |
Innoviz SG&A Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | $7.18M | $7.26M | $7.09M | $6.83M | $8.30M | $8.28M | $9.40M | $38.63M |
Avg Forecast | $178.79M | $143.03M | $81.12M | $53.64M | $43.53M | $19.81M | $20.48M | $24.92M | $50.08M | $13.35M | $4.72M | $6.32M | $10.37M | $8.61M | $9.64M | $13.06M | $7.79M | $10.02M | $6.68M |
High Forecast | $178.79M | $143.03M | $81.12M | $53.64M | $43.53M | $19.81M | $20.48M | $24.92M | $50.08M | $13.35M | $4.72M | $6.32M | $10.37M | $8.61M | $9.64M | $13.06M | $7.79M | $10.02M | $6.68M |
Low Forecast | $178.79M | $143.03M | $81.12M | $53.64M | $43.53M | $19.81M | $20.48M | $24.92M | $50.08M | $13.35M | $4.72M | $6.32M | $10.37M | $8.61M | $9.64M | $13.06M | $7.79M | $10.02M | $6.68M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.14% | 0.70% | 0.82% | 0.71% | 0.64% | 1.06% | 0.94% | 5.79% |
Innoviz EPS Forecast
Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 2 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
EPS | - | - | - | - | - | - | - | - | - | - | - | $-0.26 | $0.69 | $-0.25 | $-0.21 | $-0.23 | $-0.25 | $-0.20 | $-0.58 |
Avg Forecast | $-0.12 | $-0.12 | $-0.13 | $-0.13 | $-0.14 | $-0.13 | $-0.15 | $-0.15 | $-0.18 | $-0.22 | $-0.22 | $-0.22 | $-0.24 | $-0.24 | $-0.18 | $-0.18 | $-0.15 | $-0.16 | $1.01 |
High Forecast | $-0.12 | $-0.12 | $-0.13 | $-0.13 | $-0.14 | $-0.13 | $-0.15 | $-0.15 | $-0.18 | $-0.22 | $-0.22 | $-0.22 | $-0.24 | $-0.24 | $-0.18 | $-0.18 | $-0.15 | $-0.16 | $1.01 |
Low Forecast | $-0.12 | $-0.12 | $-0.13 | $-0.13 | $-0.14 | $-0.13 | $-0.15 | $-0.15 | $-0.18 | $-0.22 | $-0.22 | $-0.22 | $-0.24 | $-0.24 | $-0.18 | $-0.18 | $-0.15 | $-0.16 | $1.01 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | 1.18% | -2.90% | 1.06% | 1.15% | 1.28% | 1.67% | 1.25% | -0.57% |
Innoviz Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
LAZR | Luminar | $0.81 | $13.86 | 1611.11% | Buy |
LIDR | AEye | $1.06 | $12.00 | 1032.08% | Buy |
INVZ | Innoviz | $0.64 | $5.67 | 785.94% | Buy |
MBLY | Mobileye Global | $14.57 | $33.81 | 132.05% | Buy |
QS | QuantumScape | $5.09 | $11.20 | 120.04% | Hold |
HYLN | Hyliion | $2.29 | $3.13 | 36.68% | Buy |
AEVA | Aeva | $3.85 | $4.75 | 23.38% | Hold |
INVZ Forecast FAQ
Is Innoviz a good buy?
Yes, according to 4 Wall Street analysts, Innoviz (INVZ) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 3 'Buy' recommendations, accounting for 75.00% of INVZ's total ratings.
What is INVZ's price target?
Innoviz (INVZ) average price target is $5.67 with a range of $1 to $13, implying a 782.90% from its last price of $0.642. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Innoviz stock go up soon?
According to Wall Street analysts' prediction for INVZ stock, the company can go up by 782.90% (from the last price of $0.642 to the average price target of $5.67), up by 1924.29% based on the highest stock price target, and up by 55.71% based on the lowest stock price target.
Can Innoviz stock reach $1?
INVZ's average twelve months analyst stock price target of $5.67 supports the claim that Innoviz can reach $1 in the near future.
What are Innoviz's analysts' financial forecasts?
Innoviz's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $24.43M (high $24.43M, low $24.43M), average EBITDA is $-14.657M (high $-14.657M, low $-14.657M), average net income is $-94.766M (high $-94.766M, low $-94.766M), average SG&A $108.73M (high $108.73M, low $108.73M), and average EPS is $-0.569 (high $-0.569, low $-0.569). INVZ's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $102.58M (high $102.58M, low $102.58M), average EBITDA is $-61.545M (high $-61.545M, low $-61.545M), average net income is $-82.882M (high $-82.882M, low $-82.882M), average SG&A $456.57M (high $456.57M, low $456.57M), and average EPS is $-0.498 (high $-0.498, low $-0.498).
Did the INVZ's actual financial results beat the analysts' financial forecasts?
Based on Innoviz's last annual report (Dec 2022), the company's revenue was $6.03M, which missed the average analysts forecast of $9.36M by -35.64%. Apple's EBITDA was $-126M, beating the average prediction of $-5.618M by 2140.60%. The company's net income was $-127M, missing the average estimation of $-140M by -9.09%. Apple's SG&A was $29.48M, missing the average forecast of $41.68M by -29.27%. Lastly, the company's EPS was $-0.94, beating the average prediction of $-0.838 by 12.17%. In terms of the last quarterly report (Mar 2023), Innoviz's revenue was $1.01M, missing the average analysts' forecast of $1.42M by -28.87%. The company's EBITDA was $-35.809M, beating the average prediction of $-852K by 4102.93%. Innoviz's net income was $-34.8M, missing the average estimation of $-36.637M by -5.01%. The company's SG&A was $7.18M, beating the average forecast of $6.32M by 13.64%. Lastly, the company's EPS was $-0.26, beating the average prediction of $-0.22 by 18.18%